David M. Pariser

Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

Andrew Blauvelt, Marjolein de Bruin‐Weller, Melinda Gooderham et al. · The Lancet · 2017 · 1.2K citations · Full text

Medicine, Dermatology, Immunology +17

A Novel Targeted T-Cell Modulator, Efalizumab, for Plaque Psoriasis

Mark Lebwohl, Stephen K. Tyring, Tiffani K. Hamilton et al. · New England Journal of Medicine · 2003 · 580 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

A large-scale North American study of fungal isolates from nails: The frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns

Mahmoud A. Ghannoum, Rana Hajjeh, Richard Scher et al. · Journal of the American Academy of Dermatology · 2000 · 535 citations

Life Sciences, Dermatology, Microbiology +17

Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis

Eric L. Simpson, Amy S. Paller, Elaine C. Siegfried et al. · JAMA Dermatology · 2019 · 509 citations · Full text

Medicine, Dermatology, Immunology +13

Etanercept Treatment for Children and Adolescents with Plaque Psoriasis

Amy S. Paller, Elaine C. Siegfried, Richard G. Langley et al. · New England Journal of Medicine · 2008 · 388 citations · Full text

Medicine, Dermatology, Pharmacotherapy +9